Giles Tilley | Managing Director

Giles Tilley

Giles Tilley has over 35 years of Senior International Business Development & Management experience within the Natural Healthcare industries. Giles has worked closely with the Australian government for more than 15 years identifying innovative natural Australian healthcare products and technologies and guiding them from initial market entry strategy to international success, including working on Australian Manuka Honey in international markets, especially in Germany and Japan.

He has gained widespread success as an innovative entrepreneur, having stunned Australia by becoming only the second person ever in its history to sell non-alcohol specialized dermaceuticals to NASA shuttle operations in the U.S., a feat which gained him both media attention and a political citation form the Queensland State Premier. He has consulted to Medifruit Pty Ltd since 2010 and driven the Company’s international R&D program, culminating recently in a platform of patents in the pain and inflammatory category.

Since 2010 he has branched out as a specialist consultant and is retained by GenBio to advise on rare novel extracts for the U.S. market. His expertise is in start-ups and he has guided several to success in his 35-year career in this challenging area. Giles holds both a BA and MA from Oxford University.

Todd D. Sonoga | Director & Chief Marketing Officer

Todd D. Sonoga

Todd has successfully represented public and private companies for over 20 years, consulting them on market awareness, support, raising capital, identifying merger and acquisition targets, advertising, marketing & branding. In 1992, Todd was recruited by Wall Street Publishing for their ‘The Small Cap Report,’ out of Newport Beach California where he oversaw research, training, subscriber management and served as Editor of the newsletter.

Todd in 1998, founded Trilogy Marketing Strategies, Wall Street Microcap in 2013 and Crowdfunding Power in 2014. In early 2017, Todd co-founded and assumed the role of Chief Marketing Officer for WFN1 News Corp. (WFN1) and the show ‘CEO Money’ on Dallas Talk Radio Show on IHeart’s 1190 AM. Currently, Todd also owns and operates one of North America’s largest investor networks, with a total reach of over 10 million investors and is a member or administrator to over 850 investment rooms, groups, boards and affiliate investment websites.

Professor Lindsay Brown | Chief Scientific Officer | Consultant to Board

Professor Lindsay Brown

Professor Lindsay Brown is currently Professor of Biomedical Sciences, University of Southern Queensland, Australia and since 2015 a Fellow of the International Academy of Cardiovascular Science. His 35 years of scientific research encompasses an emphasis on drugs acting on the heart and associated blood vessels, endocrine organs and brain. His research team is internationally recognized for using rat models to determine whether interventions, including many natural products, can reverse or prevent disease-induced changes of the heart, liver, kidney and adipose tissue, and to indicate whether these interventions should be further tested in humans with these diseases.

His recent studies have characterized the prevention of obesity-induced osteoarthritis in rats. Further, he has reported, including National TV, the decrease in blood pressure in mildly hypertensive patients using Australian Queen Garnet plum juice. He is an editor of Nutrients and Journal of Clinical Medicine. He also holds a USQ Excellence in Research award 2015.